M. Paesmans (Brussels, Belgium), F. Gamarra (Munich, Germany)
Sleep quality, quality of life and their correlative factors in lung cancer patients
Y. Zhou, Y. Li, W. Huang, X. Cai, Q. Zeng, L. Huang (Guangzhou, China)
|  |
Preoperative anxiety can affect the quality of life and health outcome of the patients that undergo thoracic surgery
M. Anagnostopoulou, I. Vamvakaris, G. Vogiatzis, C. Sykaras, A. Maria, I. Gkiozos, A. Charpidou, K. Syrigos (Athens, Greece)
| |
Religiosity and depression of patients with lung cancer
S. Kukulj, B. Aukst-Margetic (Zagreb, Croatia)
| |
Potential role of antidepressants as part of anticancer therapy
D. Jovanovic, R. Stevic, S. Popevic, M. Velinovic, N. Samardzic, D. Maric (Belgrade, Republic Of Serbia)
|  |
Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease
M. Samulowski, C. Crolow, T. Blum, J. Kollmeier, W. Grüning, N. Schönfeld, R. C. Bittner, T. T. Bauer (Berlin, Germany)
| |
Study of the lung cancer patients on hemodialysis (HD) in Japan
R. Matsunuma, Y. Ohkuni, A. Komatsu, K. Nakashima, N. Asai, H. Makino, N. Kaneko (Kamogawa-city, Japan)
| |
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients
V. Kouranos, A. Vassias, G. Dimopoulos, K. Syrigos (Athens, Greece)
| |
A study comparing the efficacy, quality of life and toxicity of cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer in the Indian scenario
R. Aurangabadwalla, R. K. Jenaw, N. K. Jain, A. Jha, N. Jain, N. Joshi (Jaipur, India)
| |
Achieving better therapeutic results by education and telephone counseling for lung cancer patients undergoing scheduled chemotherapy regiments
S. Karagiannis, V. Kouranos, E. G. Tsaroucha, M. Palavra, S. Spyropoulou, O. Anagnostopoulou (Athens, Greece)
| |
Can exhaled nitric oxide (FeNO) predict radiotherapy-induced lung toxicity in lung cancer patients?
I. Enache, G. Noel, M. Oswald-Mammosser, M. Y. Jeung, E. Urban-Kraemer, C. Pistea, E. Quoix, A. Charloux (Strasbourg, France)
| |
Cetuximab maintenance therapy – How long should we proceed? A case report
S. Rüdiger, C. Kropf, G. Schmid-Bindert, T. Wibmer, M. Lanzinger, K. Stoiber, J. Blanta, W. Rottbauer, C. Schumann (Ulm, Mannheim, Germany)
| |
Clinical predictors for long-term benefit of cetuximab maintenance therapy – Single center subanalysis of the GEMTAX IV trial
S. Rüdiger, C. Kropf, G. Schmid-Bindert, T. Wibmer, M. Lanzinger, K. Stoiber, J. Blanta, W. Rottbauer, C. Schumann (Ulm, Mannheim, Germany)
| |
Clinicopathologic characteristics of primary bronchial cancer metastasizing to the brain
E. Podmaniczky, K. Fabian, G. Losonczy, J. Moldvay (Budapest, Hungary)
| |
Survival of lung cancer patients with bone metastases
E. Budisin, N. Budisin, M. Potic, O. Budisin, D. Vuckovic (Sremska Kamenica, Novi Sad, Republic Of Serbia)
| |
Pulmonary carcinoid tumor with multipl bone metastasis: A case report
O. Okutan, O. Ayten, E. Demirer, Z. Kartaloglu, N. Ugan (Istanbul, Turkey)
| |
Complete regression of eyeball metastasis secondary to non-small-cell lung cancer with intravitreal cisplatin and vinorelbin therapy
M. Kostrzewska, H. Batura-Gabryel, M. Nowak-Gabryel (Poznan, Poland)
| |